Corcept Therapeutics
CORT
#2078
Rank
โ‚ฌ7.79 B
Marketcap
73,96ย โ‚ฌ
Share price
1.71%
Change (1 day)
31.75%
Change (1 year)

Corcept Therapeutics (CORT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ0.16 Billion

According to Corcept Therapeutics 's latest financial reports the company's total liabilities are โ‚ฌ0.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Corcept Therapeutics - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.15 B48.93%
2023-12-31โ‚ฌ0.10 B36.55%
2022-12-31โ‚ฌ76.06 M79.64%
2021-12-31โ‚ฌ42.33 M7.61%
2020-12-31โ‚ฌ39.34 M7.16%
2019-12-31โ‚ฌ36.71 M17.29%
2018-12-31โ‚ฌ31.3 M27.03%
2017-12-31โ‚ฌ24.64 M-5.31%
2016-12-31โ‚ฌ26.02 M-14.81%
2015-12-31โ‚ฌ30.55 M-2.27%
2014-12-31โ‚ฌ31.25 M2.64%
2013-12-31โ‚ฌ30.45 M7.75%
2012-12-31โ‚ฌ28.26 M630.35%
2011-12-31โ‚ฌ3.87 M33.36%
2010-12-31โ‚ฌ2.9 M71.88%
2009-12-31โ‚ฌ1.68 M-17.7%
2008-12-31โ‚ฌ2.05 M-0.48%
2007-12-31โ‚ฌ2.06 M-23.2%
2006-12-31โ‚ฌ2.68 M-10.75%
2005-12-31โ‚ฌ3 M123.69%
2004-12-31โ‚ฌ1.34 M-96.09%
2003-12-31โ‚ฌ34.35 M-17.88%
2002-12-31โ‚ฌ41.83 M1861.19%
2001-12-31โ‚ฌ2.13 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 59,125.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ67.24 B 40,738.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ53.71 B 32,521.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚ฌ78.23 B 47,412.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ99.31 B 60,219.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ66.68 B 40,399.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ0.70 B 325.33%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ0.46 B 181.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ1.33 B 712.79%๐Ÿ‡บ๐Ÿ‡ธ USA